13/07/2022at 10:39

Chemometec CEO's wife convicted of insider trading

The wife of Chemometec CEO Steen Søndergaard receives a conditional prison sentence of 30 days for having shared information about a forthcoming guidance upgrade.

by marketwire, translated by jonas sahl hollænder

Chemometec finds itself at the center of an insider trading case after the company CEO’s wife in March 2021 leaked information on a forthcoming guidance upgrade to an acquaintance.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Dicerna CEO fears insider trading crackdown, withdraws own shares from Novo Nordisk offer
For subscribers
Rumored GN purchase unlikely but not impossible, say analysts
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Per Wold-Olsen officially stepped down as GN's chair at the company's AGM | Foto: Mik Eskestad

Hearing health

Former GN chair says there have been no acquisition signs from Demant owner

Per Wold-Olsen left the chairperson position two weeks ago after 15 years – he now reveals there haven’t been acquisition talks behind closed doors during his time at the company.

For subscribers

Regulation

CHMP recommends nine drugs in March

For subscribers

Nicolai Buhl, executive vice president for innovation at Coloplast, is busy winning a clinical contest against a catheter competitor | Foto: Mik Eskestad

Medtech

Coloplast challenges its biggest catheter competitor in clinical contest

For subscribers

Other

Top news from MedWatch this week

Pharma & biotech

Former Bavarian Nordic chairman sees opportunities in Johnson & Johnson's RSV exit

For subscribers

Pharma & biotech

Novo Nordisk helps Canada resolve Ozempic issue

For subscribers

Watchdog looking into Novo Nordisk sponsorship of patient group

The Danish drugmaker has until mid-April to produce materials related to a case concerning a sponsorship of a Danish patient organization.

For subscribers

Pharma & biotech

Novo Nordisk helps Canada resolve Ozempic issue

Americans were reportedly crossing the border seeking the diabetes drug with a strong weight-loss effect until barred from purchases.

For subscribers

Foto: Jacob Gronholt-Pedersen/Reuters/Ritzau Scanpix

Pharma & biotech

Novo Nordisk reacts to suspension: "We take the decision very seriously"

Novo Nordisk, which has been ousted from UK pharma group ABPI for two years, does not want to comment further on its punishment for misleading marketing.

For subscribers